Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Upregulation of NEK2 is associated with drug resistance in ovarian cancer

9 Dec 2013

Abstract excerpt

NEK2 [NIMA (never in mitosis gene A)-related expressed kinase 2] is associated with various biological behaviors in the development of cancer, while research concerning its association with drug resistance is limited. The association of NEK2 with drug resistance in ovarian cancer has not yet been reported. In the present study, on the basis of microarray results from Oncomine and the GEO Profiles online database,...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to MicroRNA in disease regulation
Share to Microtubule and mitosis dynamics
Share to Ovarian cancer diagnosis and treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 24337664
DOI: 10.3892/or.2013.2910

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Upregulation of NEK2 is associated with drug resistance in ovarian cancerPMID 24337664Read ↗

Targeting NEK2 as a promising therapeutic approach for cancer treatmentSemantic proximity Read ↗

A Comprehensive Analysis Revealing NEK2 as an oncogene in the Tumor MicroenvironmentSemantic proximity Read ↗

Role of NEK2A in Human Cancer and Its Therapeutic PotentialsSemantic proximity Read ↗

In-Silico Evaluation of Genetic Alterations in Ovarian Carcinoma and Therapeutic Efficacy of NSC777201, as a Novel Multi-Target Agent for TTK, NEK2, and CDK1.Semantic proximity Read ↗

NIMA-related kinase 2 regulates hepatocellular carcinoma cell growth and proliferationSemantic proximity Read ↗

The NIMA-related kinase family and cancerSemantic proximity Read ↗

NEK2 is a potential pan-cancer biomarker and immunotherapy targetSemantic proximity Read ↗

High expression of NEK2 promotes lung cancer progression and drug resistance and is regulated by mutant EGFR.Semantic proximity Read ↗

NIMA related kinase 2 promotes gastric cancer cell proliferationviaERK/MAPK signalingSemantic proximity Read ↗

NEK2 serves as a prognostic biomarker for hepatocellular carcinomaSemantic proximity Read ↗

NEK2 Promotes the Migration, Invasion, Proliferation and Drug Resistance of ESCC Through the E2F1-IGF2 PathwaySemantic proximity Read ↗

Data-Driven Discovery of a Key Regulator Cyclin A2 as a Promising Therapeutic Target in Hormone-Sensitive Cancers.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.